Evidence map›Paper›PMID 38211592›Full record

ArticleCell reports methods2024

An enhancer-AAV approach selectively targeting dentate granule cells of the mouse hippocampus.

Emmie Banks, Claire-Anne Gutekunst, Geoffrey A Vargish, Anna Eaton, Kenneth A Pelkey, Chris J McBain, James Q Zheng, Viktor Janos Oláh, Matthew J M Rowan

Open access · goldAbstract read
In one paragraph

Article in Cell reports methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Emmie BanksDepartment of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA; GDBBS Graduate Program, Laney Graduate School, Emory University, Atlanta, GA 30322, USA.
Claire-Anne GutekunstDepartment of Neurosurgery, Emory University School of Medicine, Atlanta, GA 30322, USA.
Geoffrey A VargishSection on Cellular and Synaptic Physiology, NICHD - Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, USA.
Anna EatonDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30322, USA; Human Development, National Institutes of Health (NIH), Bethesda, MD, USA.
Kenneth A PelkeySection on Cellular and Synaptic Physiology, NICHD - Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, USA.
Chris J McBainSection on Cellular and Synaptic Physiology, NICHD - Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, USA.
James Q ZhengDepartment of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Viktor Janos OláhDepartment of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: viktor.janos.olah@emory.edu.
Matthew J M RowanDepartment of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA; Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: mjrowan@emory.edu.
Emory University · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USGeorgia Institute of Technology · US

Funding

Cellular And Synaptic Physiology Of Hippocampal InterneuronsZIAHD001205 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MCBAIN, CHRIS J. · 2009 to 2025
$45.8M
Automated cell-type-specific electrophysiology for understanding circuit dysregulation in Alzheimer's DiseaseRF1AG079269 · NIA · EMORY UNIVERSITY · PI FOREST, CRAIG, ROWAN, MATTHEW J.M. · 2022 to 2024
$2.4M
Mechanistic insights of cortical hyperexcitability in ALSR21NS133960 · NINDS · EMORY UNIVERSITY · PI JIANG, JIE, QIN, ZHAOHUI · 2023 to 2024
$506k
Neuronal mechanisms of altered circuit excitability in early Alzheimer'sR56AG072473 · NIA · EMORY UNIVERSITY · PI ROWAN, MATTHEW J.M. · 2021 to 2021
$385k
NIA NIH HHS R56 AG072473NIA NIH HHS RF1 AG079269NINDS NIH HHS R21 NS133960
6 · The paper itself

Abstract

The mammalian brain contains a diverse array of cell types, including dozens of neuronal subtypes with distinct anatomical and functional characteristics. The brain leverages these neuron-type specializations to perform diverse circuit operations and thus execute different behaviors properly. Through the use of Cre lines, access to specific neuron types has improved over past decades. Despite their extraordinary utility, development and cross-breeding of Cre lines is time consuming and expensive, presenting a significant barrier to entry for investigators. Furthermore, cell-based therapeutics developed in Cre mice are not clinically translatable. Recently, several adeno-associated virus (AAV) vectors utilizing neuron-type-specific regulatory transcriptional sequences (enhancer-AAVs) were developed that overcome these limitations. Using a publicly available RNA sequencing (RNA-seq) dataset, we evaluated the potential of several candidate enhancers for neuron-type-specific targeting in the hippocampus. Here, we demonstrate that a previously identified enhancer-AAV selectively targets dentate granule cells over other excitatory neuron types in the hippocampus of wild-type adult mice.

Indexed as

Dentate GyrusNeuronsAnimalsHippocampusMammalsMiceAAVCA3CP: Neurosciencedentate gyrusenhancergene therapiesgranule cellshippocampusperforant pathviral targeting

Identifiers

PMID38211592
PMCPMC10831952
OpenAlexW4390704906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.